PCI-27483
98%
- Product Code: 62603
CAS:
871266-63-6
Molecular Weight: | 596.57 g./mol | Molecular Formula: | C₂₆H₂₄N₆O₉S |
---|---|---|---|
EC Number: | MDL Number: | ||
Melting Point: | Boiling Point: | ||
Density: | Storage Condition: | -20°C, airtight, dry |
Product Description:
PCI-27483 is primarily investigated for its potential in cancer therapy, particularly as a factor VIIa inhibitor. It targets the coagulation pathway, which is often hijacked by tumors to promote growth and metastasis. By inhibiting factor VIIa, PCI-27483 disrupts the signaling cascade that supports tumor progression, making it a promising candidate for treating cancers that rely on this pathway. Its application is especially relevant in pancreatic cancer, where coagulation factors play a significant role in disease progression. Research is ongoing to evaluate its efficacy and safety in clinical settings.
Sizes / Availability / Pricing:
Size (g) | Availability | Price | Quantity |
---|---|---|---|
0.010 | 10-20 days | ฿33,876.00 |
+
-
|
PCI-27483
PCI-27483 is primarily investigated for its potential in cancer therapy, particularly as a factor VIIa inhibitor. It targets the coagulation pathway, which is often hijacked by tumors to promote growth and metastasis. By inhibiting factor VIIa, PCI-27483 disrupts the signaling cascade that supports tumor progression, making it a promising candidate for treating cancers that rely on this pathway. Its application is especially relevant in pancreatic cancer, where coagulation factors play a significant role in disease progression. Research is ongoing to evaluate its efficacy and safety in clinical settings.
Mechanism | - |
Appearance | - |
Longevity | - |
Strength | - |
Storage | - |
Shelf Life | - |
Allergen(s) | - |
Dosage (Range) | - |
Recommended Dosage | - |
Dosage (Per Day) | - |
Recommended Dosage (Per Day) | - |
Mix Method | - |
Heat Resistance | - |
Stable in pH range | - |
Solubility | - |
Product Types | - |
INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :